According to Stratistics MRC, the Global Chronic Kidney Disease (CKD) Drugs market is expected to grow from $12.87 billion in 2016 to reach $16.13 billion by 2023 with a CAGR of 3.2%.
Sharing clinical information through a health information exchange (HIE) offers a systems-minded solution to overcome the information gap between outpatient dialysis providers and hospitals.
Renal transplant recipients had a greater risk than the general population for melanoma, according to recently published study results in JAMA Dermatology.
Kenya has only 29 nephrologists and 260 nephrology nurses handling kidney complications, including dialysis – 24 specialists to manage adult patients and five for children.
In 2015, more than two years after CMS said it was launching a value-based program focused on end-stage renal disease (ESRD), the agency finally unveiled the groups tapped to participate in the Comprehensive ESRD Care (CEC) model. There were 13 initial participants when the model started in September 2015, and this year that number has risen to 37.
Global End Stage Renal Disease (ESRD) Market with Focus on Dialysis Market Witnessed to Gain Significant Growth Till 2021
In recent years, the prevalence of end-stage renal disease, which is the most advanced stage of kidney disease has been increased.
Chronic kidney disease is a major public health problem affecting about one in eight Americans, increasing the risks of disease and death even among those with only mild decreases in kidney function. Low-cost, low-risk preventive strategies that anyone can do are needed to address the epidemic of kidney disease.
Image from www.canstockphoto.com